Alpha Peled

1.0k total citations
50 papers, 875 citations indexed

About

Alpha Peled is a scholar working on Immunology, Hematology and Molecular Biology. According to data from OpenAlex, Alpha Peled has authored 50 papers receiving a total of 875 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Immunology, 14 papers in Hematology and 10 papers in Molecular Biology. Recurrent topics in Alpha Peled's work include Immune Cell Function and Interaction (16 papers), Virus-based gene therapy research (9 papers) and Hematopoietic Stem Cell Transplantation (6 papers). Alpha Peled is often cited by papers focused on Immune Cell Function and Interaction (16 papers), Virus-based gene therapy research (9 papers) and Hematopoietic Stem Cell Transplantation (6 papers). Alpha Peled collaborates with scholars based in Israel, United States and Belgium. Alpha Peled's co-authors include Nechama Haran‐Ghera, Miriam Ben‐Yaakov, Meir Shinitzky, Moshe Mittelman, Drorit Neumann, D. Yam, Dov Zipori, Elias Shezen, Haim Ovadia and Oded Abramsky and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and The Journal of Experimental Medicine.

In The Last Decade

Alpha Peled

50 papers receiving 819 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alpha Peled Israel 16 291 286 241 179 106 50 875
S Visonneau United States 19 412 1.4× 222 0.8× 341 1.4× 126 0.7× 128 1.2× 35 999
Jacki Kornbluth United States 21 763 2.6× 371 1.3× 285 1.2× 136 0.8× 80 0.8× 53 1.3k
Tetsuo Nishiura Japan 22 384 1.3× 640 2.2× 165 0.7× 341 1.9× 44 0.4× 44 1.2k
Garvin L. Warner United States 21 807 2.8× 349 1.2× 217 0.9× 95 0.5× 114 1.1× 36 1.4k
Krzysztof Grzegorzewski United States 15 370 1.3× 312 1.1× 214 0.9× 113 0.6× 49 0.5× 34 862
Heinz‐Joachim Radzun Germany 15 289 1.0× 488 1.7× 235 1.0× 49 0.3× 69 0.7× 38 1.0k
F. M. Sirotnak United States 19 124 0.4× 404 1.4× 301 1.2× 111 0.6× 64 0.6× 42 1.0k
Keiichi I. Nakayama Japan 14 188 0.6× 745 2.6× 336 1.4× 237 1.3× 91 0.9× 22 1.2k
DW Kufe United States 16 173 0.6× 563 2.0× 223 0.9× 124 0.7× 42 0.4× 31 884
Laura Rossi Italy 21 264 0.9× 477 1.7× 216 0.9× 74 0.4× 134 1.3× 39 1.1k

Countries citing papers authored by Alpha Peled

Since Specialization
Citations

This map shows the geographic impact of Alpha Peled's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alpha Peled with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alpha Peled more than expected).

Fields of papers citing papers by Alpha Peled

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alpha Peled. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alpha Peled. The network helps show where Alpha Peled may publish in the future.

Co-authorship network of co-authors of Alpha Peled

This figure shows the co-authorship network connecting the top 25 collaborators of Alpha Peled. A scholar is included among the top collaborators of Alpha Peled based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alpha Peled. Alpha Peled is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Weil, Merav, Michael Albeck, Alpha Peled, et al.. (2006). The immunomodulator AS101 induces growth arrest and apoptosis in Multiple Myeloma: Association with the Akt/Survivin pathway. Biochemical Pharmacology. 72(11). 1423–1431. 37 indexed citations
3.
Yam, D., Alpha Peled, & Meir Shinitzky. (2000). Suppression of tumor growth and metastasis by dietary fish oil combined with vitamins E and C and cisplatin. Cancer Chemotherapy and Pharmacology. 47(1). 34–40. 57 indexed citations
4.
5.
Lee, Bai‐Chin, Yaron Shav‐Tal, Alpha Peled, et al.. (1996). A hematopoietic organ-specific 49-kD nuclear antigen: predominance in immature normal and tumor granulocytes and detection in hematopoietic precursor cells. Blood. 87(6). 2283–2291. 11 indexed citations
6.
Peled, Alpha, Esther Tzehoval, & Nechama Haran‐Ghera. (1995). Role of cytokines in termination of the B cell lymphoma dormant state in AKR mice.. PubMed. 9(6). 1095–101. 5 indexed citations
7.
Wolkowicz, Roland, Alpha Peled, N. Barry Elkind, & Varda Rotter. (1995). Augmented DNA-binding activity of p53 protein encoded by a carboxyl-terminal alternatively spliced mRNA is blocked by p53 protein encoded by the regularly spliced form.. Proceedings of the National Academy of Sciences. 92(15). 6842–6846. 24 indexed citations
8.
Haran‐Ghera, Nechama, et al.. (1995). The effects of passive antiviral immunotherapy in AKR mice: I. The susceptibility of AKR mice to spontaneous and induced T cell lymphomagenesis.. PubMed. 9(7). 1199–206. 6 indexed citations
9.
Rosner, Arie, Alpha Peled, Nechama Haran‐Ghera, & Eli Canaani. (1993). Analysis of Ly-1+ B-cell populations and IgH rearrangements in "normal" spleens and in lymphomas of AKR/J and AKR Fv-1b mice.. PubMed. 53(9). 2147–53. 8 indexed citations
10.
Haran‐Ghera, Nechama, et al.. (1992). Termination of the B cell lymphoma dormant state in thymectomized AKR mice. The Journal of Immunology. 148(9). 2947–2952. 5 indexed citations
11.
Resnitzky, P, Luba Trakhtenbrot, Alpha Peled, et al.. (1992). Absence of negative growth regulation in three new murine radiation-induced myeloid leukemia cell lines with deletion of chromosome 2.. PubMed. 6(12). 1288–95. 3 indexed citations
12.
Haran‐Ghera, Nechama & Alpha Peled. (1991). II. Prevention of spontaneous AKR T cell lymphomagenesis by elimination of potential lymphoma cells with antibody to specific gp 71 determinants. Virology. 181(2). 536–540. 2 indexed citations
13.
Peled, Alpha & Nechama Haran‐Ghera. (1991). I. Prevention of spontaneous AKR T cell lymphomagenesis by 24-666, a virus isolated from an AKR B cell lymphoma. Virology. 181(2). 528–535. 6 indexed citations
14.
Haran‐Ghera, Nechama, et al.. (1989). Preleukemia in Experimental Leukemogenesis. Hämatologie und Bluttransfusion. 32. 243–249. 6 indexed citations
15.
Resnitzky, P, et al.. (1988). Variations in surface charge distribution of leukemic and non-leukemic transformed cells. Leukemia Research. 12(4). 315–320. 5 indexed citations
16.
Peled, Alpha, et al.. (1987). Enhanced AKR leukemogenesis by the dual tropic viruses. II. Effect on cell-mediated immune responses.. PubMed. 1(5). 450–6. 5 indexed citations
17.
Peled, Alpha & Nechama Haran‐Ghera. (1985). High incidence of B cell lymphomas derived from thymectomized AKR mice expressing TL.4 antigen.. The Journal of Experimental Medicine. 162(3). 1081–1086. 15 indexed citations
18.
Peled, Alpha. (1977). Cellular immune response induced by the radiation leukemia virus (RadLV). Leukemia Research. 1(4). 333–343. 5 indexed citations
19.
Haran‐Ghera, Nechama & Alpha Peled. (1973). Thymus and Bone Marrow Derived Lymphatic Leukaemia in Mice. Nature. 241(5389). 396–398. 53 indexed citations
20.
Peled, Alpha & Nechama Haran‐Ghera. (1971). Immunosuppression by the radiation leukemia virus and its relation to lymphatic leukemia development. International Journal of Cancer. 8(1). 97–106. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by S Visonneau Breakdown of academic impact, for papers by Jacki Kornbluth Breakdown of academic impact, for papers by Tetsuo Nishiura Breakdown of academic impact, for papers by Garvin L. Warner Breakdown of academic impact, for papers by Krzysztof Grzegorzewski Breakdown of academic impact, for papers by Heinz‐Joachim Radzun Breakdown of academic impact, for papers by F. M. Sirotnak Breakdown of academic impact, for papers by Keiichi I. Nakayama Breakdown of academic impact, for papers by DW Kufe Breakdown of academic impact, for papers by Laura Rossi
Rankless by CCL
2026